Turn Therapeutics (TTRX) Current Assets (2024 - 2026)

Turn Therapeutics' Current Assets history runs 3 years deep, the most recent figure standing at $11.5 million for Q1 2026.

• In Q1 2026, Current Assets changed N/A year-over-year to $11.5 million; the TTM figure through Mar 2026 stood at $11.5 million (changed N/A YoY), while the FY2025 annual figure was $5.2 million, up 373.3% from the prior year.
• Current Assets for Q1 2026 stood at $11.5 million, up from $5.2 million in the prior quarter.
• The five-year high for Current Assets was $11.5 million in Q1 2026, with the low at $1.1 million in Q4 2024.
• The 3-year median for Current Assets is $4.2 million (2025), against an average of $5.3 million.
• Peak annual rise in Current Assets reached 373.3% in 2025, while the deepest fall reached 373.3% in 2025.
• Turn Therapeutics' Current Assets stood at $1.1 million in 2024, then soared by 373.3% to $5.2 million in 2025, then soared by 120.4% to $11.5 million in 2026.
• Business Quant data shows TTRX's Current Assets at $11.5 million in Q1 2026, $5.2 million in Q4 2025, and $3.3 million in Q3 2025.